Literature DB >> 16547751

P2X purinoceptors and sensory transmission.

Terumasa Nakatsuka1, Jianguo G Gu.   

Abstract

The involvement of P2X purinoreceptors (P2X receptors) in somatosensory transmission is herein reviewed with a focus on those receptors that are expressed on sensory neurons to elucidate their roles in the initiation of sensory excitation from primary afferent neurons, in modulating synaptic transmission at the first sensory synapses formed between primary afferent central terminals and dorsal horn neurons, in directly mediating sensory synaptic transmission to the spinal cord dorsal horn, and in modulating synaptic transmission among spinal cord dorsal horn neurons. Research on P2X receptors has indicated that these receptors play a significant role in both physiological and pathological pain states. As a result, P2X receptors may serve as therapeutic targets for the treatment of pathological pain conditions associated with nerve injury, tissue inflammation, cancer, and other diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16547751     DOI: 10.1007/s00424-006-0057-6

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  84 in total

1.  Inflammatory mediators potentiate ATP-gated channels through the P2X(3) subunit.

Authors:  M Paukert; R Osteroth; H S Geisler; U Brandle; E Glowatzki; J P Ruppersberg; S Gründer
Journal:  J Biol Chem       Date:  2001-03-22       Impact factor: 5.157

2.  The effects of inflammation and inflammatory mediators on nociceptive behaviour induced by ATP analogues in the rat.

Authors:  S G Hamilton; A Wade; S B McMahon
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

3.  Presynaptic P2X receptors facilitate inhibitory GABAergic transmission between cultured rat spinal cord dorsal horn neurons.

Authors:  S Hugel; R Schlichter
Journal:  J Neurosci       Date:  2000-03-15       Impact factor: 6.167

Review 4.  Spinal and trigeminal mechanisms of nociception.

Authors:  R Dubner; G J Bennett
Journal:  Annu Rev Neurosci       Date:  1983       Impact factor: 12.449

5.  Distinct ATP-activated currents in different types of neurons dissociated from rat dorsal root ganglion.

Authors:  C Li; R W Peoples; T H Lanthorn; Z W Li; F F Weight
Journal:  Neurosci Lett       Date:  1999-03-19       Impact factor: 3.046

6.  ATP facilitates spontaneous glycinergic IPSC frequency at dissociated rat dorsal horn interneuron synapses.

Authors:  J S Rhee; Z M Wang; J Nabekura; K Inoue; N Akaike
Journal:  J Physiol       Date:  2000-04-15       Impact factor: 5.182

7.  P2X3 is expressed by DRG neurons that terminate in inner lamina II.

Authors:  L Vulchanova; M S Riedl; S J Shuster; L S Stone; K M Hargreaves; G Buell; A Surprenant; R A North; R Elde
Journal:  Eur J Neurosci       Date:  1998-11       Impact factor: 3.386

8.  Observations on the algogenic actions of adenosine compounds on the human blister base preparation.

Authors:  Tirza Bleehen; C A Keele
Journal:  Pain       Date:  1977-08       Impact factor: 6.961

9.  TNP-ATP-resistant P2X ionic current on the central terminals and somata of rat primary sensory neurons.

Authors:  Kenzo Tsuzuki; Ariel Ase; Philippe Séguéla; Terumasa Nakatsuka; Cong-Yi Wang; Jin-Xiong She; Jianguo G Gu
Journal:  J Neurophysiol       Date:  2003-06       Impact factor: 2.714

10.  Enkephalins modulate excitatory synaptic transmission in the superficial dorsal horn by acting at mu-opioid receptor sites.

Authors:  S Jeftinija
Journal:  Brain Res       Date:  1988-09-20       Impact factor: 3.252

View more
  32 in total

Review 1.  Extracellular ATP and other nucleotides-ubiquitous triggers of intercellular messenger release.

Authors:  Herbert Zimmermann
Journal:  Purinergic Signal       Date:  2015-11-06       Impact factor: 3.765

2.  Localization of P2X2 and P2X3 receptors in rat trigeminal ganglion neurons.

Authors:  V Staikopoulos; B J Sessle; J B Furness; E A Jennings
Journal:  Neuroscience       Date:  2006-11-15       Impact factor: 3.590

3.  Physiological and pathological functions of P2X7 receptor in the spinal cord.

Authors:  Maria Luisa Cotrina; Maiken Nedergaard
Journal:  Purinergic Signal       Date:  2009-02-11       Impact factor: 3.765

4.  Roles of purines in synaptic modulation evoked by hypercapnia in isolated spinal cord of neonatal rat in vitro.

Authors:  K Otsuguro; M Ban; T Ohta; S Ito
Journal:  Br J Pharmacol       Date:  2009-04       Impact factor: 8.739

5.  Activation of P2X7 receptors in glial satellite cells reduces pain through downregulation of P2X3 receptors in nociceptive neurons.

Authors:  Yong Chen; Xiaofei Zhang; Congying Wang; Guangwen Li; Yanping Gu; Li-Yen Mae Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-22       Impact factor: 11.205

Review 6.  Extending the knowledge in histochemistry and cell biology.

Authors:  Wolfgang-Moritz Heupel; Detlev Drenckhahn
Journal:  Histochem Cell Biol       Date:  2009-11-28       Impact factor: 4.304

7.  Distribution of purinergic P2X receptors in the equine digit, cervical spinal cord and dorsal root ganglia.

Authors:  D E Zamboulis; J M Senior; P D Clegg; J A Gallagher; S D Carter; P I Milner
Journal:  Purinergic Signal       Date:  2013-02-06       Impact factor: 3.765

8.  Distribution of P2X(3) receptor immunoreactivity in myenteric ganglia of the mouse esophagus.

Authors:  Christine Kestler; Winfried L Neuhuber; Marion Raab
Journal:  Histochem Cell Biol       Date:  2008-09-20       Impact factor: 4.304

9.  Glutamate-mediated astrocyte-to-neuron signalling in the rat dorsal horn.

Authors:  Rita Bardoni; Alessia Ghirri; Micaela Zonta; Chiara Betelli; Giovanni Vitale; Valentina Ruggieri; Maurizio Sandrini; Giorgio Carmignoto
Journal:  J Physiol       Date:  2010-01-18       Impact factor: 5.182

10.  Behavioral phenotypes of mice lacking purinergic P2X4 receptors in acute and chronic pain assays.

Authors:  Makoto Tsuda; Kazuya Kuboyama; Tomoyuki Inoue; Kenichiro Nagata; Hidetoshi Tozaki-Saitoh; Kazuhide Inoue
Journal:  Mol Pain       Date:  2009-06-11       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.